Fonterra sells stake in joint venture DFE Pharma for US$361.8m

NEW ZEALAND – Fonterra has completed the sale of its 50% stake in the joint venture company it formed with Royal FrieslandCampina, DFE Pharma to CVC Strategic Opportunities II for NZD554 million (US$361.83m). The company […]

Fonterra offloads 50% stake in DFE Pharma in debt management strategy

NEW ZEALAND – Fonterra has agreed to sell its 50 percent stake in DFE Pharma, a joint venture with Royal Friesland Campina, for NZD 633 million (US$401 million). The 50% stake in DFE Pharma will be […]